covid
Buscar en
Progresos de Obstetricia y Ginecología
Toda la web
Inicio Progresos de Obstetricia y Ginecología Radicales libres de oxígeno y su relación con enfermedades específicas del em...
Información de la revista
Vol. 46. Núm. 3.
Páginas 122-135 (enero 2003)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 46. Núm. 3.
Páginas 122-135 (enero 2003)
Acceso a texto completo
Radicales libres de oxígeno y su relación con enfermedades específicas del embarazo
Relationship between oxygen free radicals and pregnancyrelated conditions
Visitas
7692
L.P. Rossala, J. Gaytána, J. Bellvera, C. Laraa, A. Pellicera,b,c, J. Remohía,c, V. Serraa,c,
Autor para correspondencia
ummf@ivi.es

Correspondencia: Unidad de Medicina Materno-Fetal. Instituto Valenciano de Infertilidad. Plaza de la Policía Local, 3. 46015 Valencia. España
a Instituto Valenciano de Infertilidad. Valencia. Facultad de Medicina. Universidad de Valencia. España
b Hospital Universitario Dr. Peset. Valencia. Facultad de Medicina. Universidad de Valencia. España
c Departamento de Pediatría, Obstetricia y Ginecología. Facultad de Medicina. Universidad de Valencia. España
Este artículo ha recibido
Información del artículo
Resumen
Bibliografía
Descargar PDF
Estadísticas
Resumen

De forma reciente se han publicado estudios que relacionan los radicales libres de oxígeno con enfermedades específicas del embarazo. En el parto pretérmino, el óxido nítrico puede estar involucrado en la quiescencia fisiológica del útero y la colagenólisis asociada con el reblandecimiento tisular del cérvix. Respecto a la rotura prematura de membranas, se conoce que la fuerza del amnios deriva del colágeno; que su degradación es controlada por las metaloproteinasas de la matriz, y que una alteración del balance entre los pro y los antioxidantes aumenta la actividad de éstas últimas. En la preeclampsia, la placentación defectuosa produce vasoconstricción, con baja perfusión placentaria, y se cree que ésta estimula la liberación de factores que llevan a una alteración funcional del endotelio vascular; así, los radicales libres han emergido como probables promotores de esta alteración funcional. Se revisa el papel potencialmente preventivo de los antioxidantes (vitaminas C y E) para intentar regularizar el balance redox, en la prevención de las citadas enfermedades.

Palabras clave:
Radicales libres de oxígeno
Parto prematuro
Rotura prematura de membranas
Preeclampsia
Summary

Recent studies have implicated oxygen free radicals with various pregnancy-related conditions. In preterm delivery, nitric oxide may be involved in the physiologic maintenance of uterine quiescence and collagen lysis associated with cervical ripening. With respect to premature rupture of membranes, the strength of the amnion is derived from collagen, its lysis is controlled by matrix metalloproteinases, and an imbalance between proand antioxidants increases the activity of these enzymes. In preeclampsia, an abnormal placentation leads to vasospasm and poor placental perfusion, releasing factors causing endothelial dysfunction. Oxygen free radicals may promote endothelial dysfunction. The potential prophylactic role of antioxidants (vitamins C and E) in regulating the redox balance and thus in preventing the development of these obstetric problems is reviewed.

keywords:
Oxygen free radicals
Preterm delivery
Premature rupture of membranes
Preeclampsia
El Texto completo está disponible en PDF
Bibliografía
[1.]
J. Navarro-Cid, V. Cachofeiro, R. Maeso, V. Lahera.
Fisiología de la pared vascular.
Fisiología humana, 2.a ed, pp. 531-539
[2.]
I. Buhimschi, C.P. Weiner.
Oxygen free radicals and disorders of pregnancy.
Fetal Maternal Med Rev, 12 (2001), pp. 273-298
[3.]
R.F. Furchgott.
Introduction to EDRF research.
J Cardiovasc Pharmacol, 22 (1993), pp. S1-S2
[4.]
R.F. Furchgott.
A research trail over half a century.
Annu Rev Pharmacol Toxicol, 35 (1995), pp. 1-27
[5.]
R.F. Furchgott.
An historical survey and prospects of research on EDRF.
Nippon Heikatsukin Gakkai Zasshi, 23 (1987), pp. 435-440
[6.]
R.F. Furchgott, W. Martin.
Interactions of endothelial cells and smooth muscle cells of arteries.
Chest, 88 (1985), pp. S210-S213
[7.]
R.M. Palmer, A.G. Ferrige, S. Moncada.
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor.
Nature, 327 (1987), pp. 524-526
[8.]
S. Moncada.
The first Robert Furchgott lecture: from endothelium-dependent relaxation to the L-arginine: NO pathway.
Blood Vessels, 27 (1990), pp. 208-217
[9.]
R.F. Furchgott, P.M. Vanhoutte.
Endothelium-derived relaxing and contracting factors.
Faseb J, 3 (1989), pp. 2007-2018
[10.]
G.A. Rongen, P. Smits, T. Thien.
Endothelium and the regulation of vascular tone with emphasis on the role of nitric oxide. Physiology, pathophysiology and clinical implications.
Neth J Med, 44 (1994), pp. 26-35
[11.]
U. Forstermann, H.H. Schmidt, J.S. Pollock, H. Sheng, J.A. Mitchell, T.D. Warner, et al.
Isoforms of nitric oxide synthase. Characterization and purification from different cell types.
Biochem Pharmacol, 42 (1991), pp. 1849-1857
[12.]
K. Naruse, M. Sokabe.
Involvement of stretch-activated ion channels in Ca2+ mobilization to mechanical stretch in endothelial cells.
Am J Physiol, 264 (1993), pp. C1037-C1044
[13.]
N. Toda, T. Okamura.
Endothelium-derived relaxing factor (EDRF).
Nippon Yakurigaku Zasshi, 95 (1990), pp. 295-308
[14.]
S. Moncada, R.M. Palmer, E.A. Higgs.
Nitric oxide: physiology, pathophysiology, and pharmacology.
Pharmacol Rev, 43 (1991), pp. 109-142
[15.]
R.A. Rhoades, G.A. Tanner.
Circulación pulmonar. Relación ventilación-perfusión.
Fisiología Médica, pp. 431-447
[16.]
D.A. Wink, J.B. Mitchell.
Chemical biology of nitric oxide: insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide.
Free Radical Biol Med, 25 (1998), pp. 434-456
[17.]
J.F. Ward.
The complexity of DNA damage: relevance to biological consequences.
Int J Radiat Biol, 66 (1994), pp. 427-432
[18.]
P.K. Kim, R. Zamora, P. Petrosko, T.R. Billiar.
The regulatory role of nitric oxide in apoptosis.
Int Immunopharmacol, 1 (2001), pp. 1421-1441
[19.]
E.I. Aruoma.
Nutrition and healthy aspects of free radicals and antioxidants.
Food Chem Tox, 32 (1994), pp. 671-683
[20.]
D.J. Dudley.
Preterm labor: an intra-uterine inflammatory response syndrome?.
J Reprod Immunol, 36 (1997), pp. 93-109
[21.]
R.S. Gibbs, R. Romero, S.L. Hillier, D.A. Eschenbach, R.L. Sweet.
A review of premature birth and subclinical infection.
Am J Obstet Gynecol, 166 (1992 May), pp. 1515-1528
[22.]
J.S. Beckman, J.P. Crow.
Pathological implications of nitric oxide, superoxide and peroxynitrite formation.
Biochem Soc Trans, 21 (1993), pp. 330-334
[23.]
C.P. Weiner, R.G. Knowles, S.E. Nelson, L.D. Stegink.
Pregnancy increases guanosine 3',5'-monophosphate in the myometrium independent of nitric oxide synthesis.
Endocrinology, 135 (1994), pp. 2473-2478
[24.]
I.A. Buhimschi, G.R. Sadee, K. Chwalisz, R.E. Garfield.
The nitric oxid pathway in preeclampsia: pathophysiological implications.
Hum Reprod Update, 4 (1998), pp. 25-42
[25.]
C. Yallampalli, H. Izumi, M. Byam-Smith, R.E. Garfield.
An L-arginine-nitric oxid-cyclic guanosine monophosphate system exist in the uterus and inhibits contractility during pregnancy.
Am J Obstet Gynecol, 170 (1994), pp. 175-185
[26.]
S.M. Sladek, A. Kanbour-Shakir, S. Watkins, K.A. Berghorn, G.E. Hoffman, J.M. Roberts.
Granulated metrial gland cells contain nitric oxide synthases during pregnancy in the rat.
Placenta, 19 (1998), pp. 55-65
[27.]
I.A. Buhimschi, C. Yallampalli, I.L. Dong, R.E. Garfield.
Involvement of a nitric oxide-cGMP pathway in control of human uterine contractility during pregnancy.
Am J Obstet Gynecol, 172 (1995), pp. 1577-1584
[28.]
T.M. Malak, C. Ockleford, S. Bell, R. Dalgleish, N. Bright, J. Macivar.
Confocal inmunofluorescence localization of collagen types I, III, IV, V and VI and their ultrastuctural organization in term human fetal membranes.
Placenta, 14 (1993), pp. 385-406
[29.]
R.K. Murray, F.W. Kelley.
The extracellular matrix.
Harper's biochemestry, pp. 634-646
[30.]
S.J. Fortunato, R. Menon, S.J. Lonbardi.
Collagenolytic encimes (gelatinases) and their inhibitors in human amniochorionic membrane.
Am J Obstet Gynecol, 177 (1997), pp. 731-741
[31.]
J.F. Woessner.
Matrix metalloproteinases and their inhibitors in connective tissue remodeling.
Faseb J, 5 (1991), pp. 2145-2154
[32.]
J.A. McGregor, J.I. French, D. Lawellin, A. Franco-Buff, C. Smith, J.K. Todd.
Bacterial portease-induced reduction of choroamniotic membrane strength and elasticity.
Obstet Gynecol, 69 (1987), pp. 167-174
[33.]
J.N. Schoonmaker, D. Lawellin, B. Lunt, J.A. McGregor.
Bacteria and inflamatory cells reduce choroamniotic membrane integrity and tensile strenght.
Obstet Gynecol, 74 (1989), pp. 590-596
[34.]
D. Drapper, J.A. McGregor, J. Hall, W. Jones, M. Beautz, R.P. Heine, et al.
Elevated portease activities in human amnion and chorion correlate with preterm premature rupture of membranes.
Am J Obstet Gynecol, 173 (1995), pp. 1506-1512
[35.]
R. Romero, C. Ávila, C.A. Brekus, M. Mazor.
The role of systemic and intrauterine infection in preterm parturition.
Uterine contractility. Serono Symposia. Norwell:, pp. 319-354
[36.]
T. So.
The role of matrix metalloproteinases for premature rupture of membranes. Nipon Sanka Fujinka Gakkai Zasshi-Acta.
Obstet Gynecol Japonica, 45 (1993), pp. 227-233
[37.]
S.J. Fortunato, R. Menon, S.J. Lonbardi.
Stromelysins in placental membranes and amniotic fluid with premature rupture of membranes.
Am J Obstet Gynecol, 94 (1999), pp. 435-440
[38.]
E. Maymon, R. Romero, P. Pacora, M.-.T. Gervasi, K. Bianco, F. Ghezzi, et al.
Evidence for the participation of interstitial collagenase in preterm premature rupture of membranes.
Am J Obstet Gynecol, 183 (2000), pp. 914-920
[39.]
I.A. Buhimschi, W.B. Kramer, C.S. Buhimschi, L.P. Thompson, C.P. Weiner.
Reduction-oxidation state regulation of matrix metalloproteinase activity in human fetal membranes.
Am J Obstet Gynecol, 182 (2000), pp. 458-464
[40.]
M. Romero, R. Mazor, K. Wuy, C. Ávila, E. Oyarzun, M.D. Mitchell.
Bacterial endotoxin and tumor necrosing factor stimulate prostaglandin production by human decidua.
Prostaglandins Leukot Essent Fatty Acids, 37 (1989), pp. 183-186
[41.]
Y. Sibille, J.S. Lwebuga-Mukasa, L. Polomskii, W.W. Merril, D.H. Ingbar, J.B.L. Gee.
Can in vitro model for polymorphonuclear leukocyte-induced injury to an extracellular matriz.
Ann Rev Respiratory Disease, 134 (1986), pp. 134-140
[42.]
G.L. Winterbourn, W.B. Essman.
Neutrophil oxidants: production and reactions.
Oxigen radicals: systemic events and desease processes, pp. 31-70
[43.]
J.R. Woods Jr..
Reactive oxygen species and preterm premature rupture of membranes-a review.
Placenta, 22 (2001), pp. S38-S44
[44.]
L.M. Postovit, M.A. Adams, C.H. Graham.
Does nitric oxide play a role in the aetiology of pre-eclampsia?.
Placenta, 22 (2001), pp. S51-S55
[45.]
L.C. Chappell, P.T. Seed, A.L. Briley, F.J. Kelly, R. Lee, B.J. Hunt, et al.
Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial.
[46.]
A.M. Agha, A.S. El-Khatib, H. Al-Zuhair.
Modulation of oxidant status by meloxicam in experimentally induced arthritis.
Pharmacol Res, 40 (1999), pp. 385-392
[47.]
G.P. Rossi, T.M. Seccia, G.G. Nussdorfer.
Reciprocal regulation of endothelin-1 and nitric oxide: relevance in the physiology and pathology of the cardiovascular system.
Int Rev Cytol, 209 (2001), pp. 241-272
[48.]
L.M. Khachigian, T. Collins, J.W. Fries.
N-acetyl cysteine blocks mesangial VCAM-1 and NF-kappa B expression in vivo.
Am J Pathol, 151 (1997), pp. 1225-1229
[49.]
B. Halliwell, J.M.C. Gutteridge, C.E. Cross.
Free radicals, antioxidants and human disease: where are we now?.
J Lab Clin Med, 119 (1992), pp. 598-620
[50.]
G.L. Squadrito, W.A. Pryor.
Oxidative chemistry of nitric oxide: the roles of superoxide, peroxynitrite, and carbon dioxide.
Free Radic Biol Med, 25 (1998), pp. 392-403
[51.]
J.C. Gessin, D. Darr, R. Kaufman, S. Murad, S.R. Pinnel.
Ascorbic acid specifically increases type I and Type III procollagen messenger RNA levels in human skin fibroblasts.
J Invest Dermatol, 90 (1988), pp. 420-424
[52.]
E. Casanueva, H. Ávila-Rosas, E. Polo, E. Tejer, M.C. Narcio-Reyes, F. Pfeffer.
Vitamin C status, cervico-vaginal infection and premature rupture of amniotic membranes.
Arch Med Res, 26 (1995), pp. 5149-5152
[53.]
M.K. Sharma, G.R. Buettner.
Interaction of vitamin C and vitamin E during free radical stress in plasma: an ESR study.
Free Rad Biol Med, 14 (1993), pp. 649-653
[54.]
M. Levine, C. Conry-Cantilena, Y. Wang, R.W. Welch, P.W. Washiko, K.R. Dhaziwal, et al.
Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance.
Prod Natl Acad Sci USA, 93 (1996), pp. 3704-3709
[55.]
N.G. Stephens, A. Parsons, P.M. Schofield, F. Kelly, K. Cheeseman, M.J. Mitchinson.
Randomised controlled trial of vitamin E in patients with coronary desease: Cambridge Heart Antioxidant Study (CHAOS).
Lancet, 347 (1996), pp. 781-786
Copyright © 2003. Sociedad Española de Ginecología y Obstetricia
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos